These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25157181)
21. CDK4 and CDK6 kinases: From basic science to cancer therapy. Fassl A; Geng Y; Sicinski P Science; 2022 Jan; 375(6577):eabc1495. PubMed ID: 35025636 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Fåhraeus R; Laín S; Ball KL; Lane DP Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104 [TBL] [Abstract][Full Text] [Related]
23. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin. Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567 [TBL] [Abstract][Full Text] [Related]
24. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling. Kundumani-Sridharan V; Singh NK; Kumar S; Gadepalli R; Rao GN J Biol Chem; 2013 Jul; 288(30):22150-62. PubMed ID: 23737530 [TBL] [Abstract][Full Text] [Related]
25. From cell cycle to differentiation: an expanding role for cdk6. Grossel MJ; Hinds PW Cell Cycle; 2006 Feb; 5(3):266-70. PubMed ID: 16410727 [TBL] [Abstract][Full Text] [Related]
26. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6. Noh SJ; Li Y; Xiong Y; Guan KL Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200 [TBL] [Abstract][Full Text] [Related]
27. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383 [TBL] [Abstract][Full Text] [Related]
29. CDK6 kinase activity is required for thymocyte development. Hu MG; Deshpande A; Schlichting N; Hinds EA; Mao C; Dose M; Hu GF; Van Etten RA; Gounari F; Hinds PW Blood; 2011 Jun; 117(23):6120-31. PubMed ID: 21508411 [TBL] [Abstract][Full Text] [Related]
30. Invasive melanoma in Cdk4-targeted mice. Sotillo R; García JF; Ortega S; Martin J; Dubus P; Barbacid M; Malumbres M Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13312-7. PubMed ID: 11606789 [TBL] [Abstract][Full Text] [Related]
31. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J; Wei T; Lahti JM; Kidd VJ Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589 [TBL] [Abstract][Full Text] [Related]
32. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141 [TBL] [Abstract][Full Text] [Related]
35. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component. Xu G; Li JY J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788 [TBL] [Abstract][Full Text] [Related]
36. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. Carbone CJ; Graña X; Reddy EP; Haines DS Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323 [TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs. De Dominici M; Porazzi P; Xiao Y; Chao A; Tang HY; Kumar G; Fortina P; Spinelli O; Rambaldi A; Peterson LF; Petruk S; Barletta C; Mazo A; Cingolani G; Salvino JM; Calabretta B Blood; 2020 Apr; 135(18):1560-1573. PubMed ID: 32040545 [TBL] [Abstract][Full Text] [Related]
38. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117 [TBL] [Abstract][Full Text] [Related]
39. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Wang H; Nicolay BN; Chick JM; Gao X; Geng Y; Ren H; Gao H; Yang G; Williams JA; Suski JM; Keibler MA; Sicinska E; Gerdemann U; Haining WN; Roberts TM; Polyak K; Gygi SP; Dyson NJ; Sicinski P Nature; 2017 Jun; 546(7658):426-430. PubMed ID: 28607489 [TBL] [Abstract][Full Text] [Related]
40. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells. Jia Y; Domenico J; Swasey C; Wang M; Gelfand EW; Lucas JJ PLoS One; 2014; 9(5):e97448. PubMed ID: 24848372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]